Monash IVF Group Ltd. announced the appointment of Mr. David Morris as the CEO and MD, effective 13 November 2017. David has more than 20 years of leadership, international business development and strategy experience. Over his 13 years at Cochlear Limited, David served as Chief Strategy Officer, having previously served as President of Cochlear Bone Anchored Solutions and as Senior Vice President of Business Development.

Prior to joining Cochlear Limited, David worked at Accenture in the strategy practice. David has extensive experience internationally and domestically in the healthcare, consumer products, utilities, and financial services industries.